| UniProt ID | RMD3_HUMAN | |
|---|---|---|
| UniProt AC | Q96TC7 | |
| Protein Name | Regulator of microtubule dynamics protein 3 | |
| Gene Name | RMDN3 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 470 | |
| Subcellular Localization |
Mitochondrion membrane Single-pass membrane protein. Mitochondrion outer membrane. Cytoplasm. Nucleus. Cytoplasm, cytoskeleton, spindle. Cytoplasm, cytoskeleton, spindle pole. In interphase localizes in the cytoplasm, and during mitosis localizes to |
|
| Protein Description | Involved in cellular calcium homeostasis regulation. May participate in differentiation and apoptosis of keratinocytes. Overexpression induces apoptosis.. | |
| Protein Sequence | MSRLGALGGARAGLGLLLGTAAGLGFLCLLYSQRWKRTQRHGRSQSLPNSLDYTQTSDPGRHVMLLRAVPGGAGDASVLPSLPREGQEKVLDRLDFVLTSLVALRREVEELRSSLRGLAGEIVGEVRCHMEENQRVARRRRFPFVRERSDSTGSSSVYFTASSGATFTDAESEGGYTTANAESDNERDSDKESEDGEDEVSCETVKMGRKDSLDLEEEAASGASSALEAGGSSGLEDVLPLLQQADELHRGDEQGKREGFQLLLNNKLVYGSRQDFLWRLARAYSDMCELTEEVSEKKSYALDGKEEAEAALEKGDESADCHLWYAVLCGQLAEHESIQRRIQSGFSFKEHVDKAIALQPENPMAHFLLGRWCYQVSHLSWLEKKTATALLESPLSATVEDALQSFLKAEELQPGFSKAGRVYISKCYRELGKNSEARWWMKLALELPDVTKEDLAIQKDLEELEVILRD | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 44 | Phosphorylation | RTQRHGRSQSLPNSL HHHHCCCCCCCCCCC | 28.81 | 29255136 | |
| 46 | Phosphorylation | QRHGRSQSLPNSLDY HHCCCCCCCCCCCCC | 47.22 | 25159151 | |
| 50 | Phosphorylation | RSQSLPNSLDYTQTS CCCCCCCCCCCCCCC | 22.22 | 23927012 | |
| 53 | Phosphorylation | SLPNSLDYTQTSDPG CCCCCCCCCCCCCCC | 13.17 | 23927012 | |
| 54 | Phosphorylation | LPNSLDYTQTSDPGR CCCCCCCCCCCCCCC | 25.66 | 20164059 | |
| 56 | Phosphorylation | NSLDYTQTSDPGRHV CCCCCCCCCCCCCEE | 27.57 | 23927012 | |
| 57 | Phosphorylation | SLDYTQTSDPGRHVM CCCCCCCCCCCCEEE | 31.80 | 23927012 | |
| 77 | Phosphorylation | PGGAGDASVLPSLPR CCCCCCCHHCCCCCC | 29.00 | 28857561 | |
| 113 | Phosphorylation | REVEELRSSLRGLAG HHHHHHHHHHHHHHH | 46.48 | 21406692 | |
| 114 | Phosphorylation | EVEELRSSLRGLAGE HHHHHHHHHHHHHHH | 18.69 | 20068231 | |
| 149 | Phosphorylation | FPFVRERSDSTGSSS CCCEEECCCCCCCCC | 31.03 | 22817900 | |
| 151 | Phosphorylation | FVRERSDSTGSSSVY CEEECCCCCCCCCEE | 35.59 | 22817900 | |
| 152 | Phosphorylation | VRERSDSTGSSSVYF EEECCCCCCCCCEEE | 46.18 | 22817900 | |
| 154 | Phosphorylation | ERSDSTGSSSVYFTA ECCCCCCCCCEEEEE | 21.38 | 22817900 | |
| 155 | Phosphorylation | RSDSTGSSSVYFTAS CCCCCCCCCEEEEEC | 25.76 | 22817900 | |
| 156 | Phosphorylation | SDSTGSSSVYFTASS CCCCCCCCEEEEECC | 23.64 | 22817900 | |
| 176 | Phosphorylation | DAESEGGYTTANAES ECCCCCCCCCCCCCC | 16.27 | 22544307 | |
| 177 | Phosphorylation | AESEGGYTTANAESD CCCCCCCCCCCCCCC | 23.78 | - | |
| 183 | Phosphorylation | YTTANAESDNERDSD CCCCCCCCCCCCCCC | 43.24 | 24275569 | |
| 189 | Phosphorylation | ESDNERDSDKESEDG CCCCCCCCCCCCCCC | 57.72 | 21815630 | |
| 193 | Phosphorylation | ERDSDKESEDGEDEV CCCCCCCCCCCCCCH | 46.88 | 23927012 | |
| 201 | Phosphorylation | EDGEDEVSCETVKMG CCCCCCHHHEEEECC | 12.28 | 21815630 | |
| 204 | Phosphorylation | EDEVSCETVKMGRKD CCCHHHEEEECCCCC | 29.74 | 29759185 | |
| 206 | Ubiquitination | EVSCETVKMGRKDSL CHHHEEEECCCCCCC | 42.95 | - | |
| 210 | Sumoylation | ETVKMGRKDSLDLEE EEEECCCCCCCCHHH | 46.03 | - | |
| 210 | Ubiquitination | ETVKMGRKDSLDLEE EEEECCCCCCCCHHH | 46.03 | - | |
| 212 | Phosphorylation | VKMGRKDSLDLEEEA EECCCCCCCCHHHHH | 27.15 | 25159151 | |
| 221 | Phosphorylation | DLEEEAASGASSALE CHHHHHHCCHHHHHH | 41.77 | 30278072 | |
| 224 | Phosphorylation | EEAASGASSALEAGG HHHHCCHHHHHHHCC | 21.48 | 25159151 | |
| 225 | Phosphorylation | EAASGASSALEAGGS HHHCCHHHHHHHCCC | 36.02 | 28176443 | |
| 232 | Phosphorylation | SALEAGGSSGLEDVL HHHHHCCCCCHHHHH | 21.95 | 25159151 | |
| 233 | Phosphorylation | ALEAGGSSGLEDVLP HHHHCCCCCHHHHHH | 51.15 | 29632367 | |
| 272 | Phosphorylation | NNKLVYGSRQDFLWR CCCCCCCCHHHHHHH | 14.74 | 24719451 | |
| 284 | Phosphorylation | LWRLARAYSDMCELT HHHHHHHHHHHHHHC | 10.31 | 23898821 | |
| 285 | Phosphorylation | WRLARAYSDMCELTE HHHHHHHHHHHHHCH | 20.20 | 23898821 | |
| 291 | Phosphorylation | YSDMCELTEEVSEKK HHHHHHHCHHHHHHC | 14.06 | 23898821 | |
| 295 | Phosphorylation | CELTEEVSEKKSYAL HHHCHHHHHHCCCCC | 47.15 | 23898821 | |
| 298 | 2-Hydroxyisobutyrylation | TEEVSEKKSYALDGK CHHHHHHCCCCCCCH | 44.65 | - | |
| 305 | 2-Hydroxyisobutyrylation | KSYALDGKEEAEAAL CCCCCCCHHHHHHHH | 52.64 | - | |
| 305 | Ubiquitination | KSYALDGKEEAEAAL CCCCCCCHHHHHHHH | 52.64 | - | |
| 314 | Acetylation | EAEAALEKGDESADC HHHHHHHHCCCCCHH | 72.94 | 19413330 | |
| 318 | Phosphorylation | ALEKGDESADCHLWY HHHHCCCCCHHHHHH | 33.86 | 19413330 | |
| 325 | Phosphorylation | SADCHLWYAVLCGQL CCHHHHHHHHHHHHH | 8.00 | 19413330 | |
| 337 | Phosphorylation | GQLAEHESIQRRIQS HHHHCHHHHHHHHHC | 26.40 | 19413330 | |
| 344 | Phosphorylation | SIQRRIQSGFSFKEH HHHHHHHCCCCHHHH | 39.16 | 24961811 | |
| 347 | Phosphorylation | RRIQSGFSFKEHVDK HHHHCCCCHHHHHHH | 38.65 | 19413330 | |
| 388 | Phosphorylation | WLEKKTATALLESPL HHHHHHHHHHHHCCC | 24.06 | - | |
| 393 | Phosphorylation | TATALLESPLSATVE HHHHHHHCCCCCCHH | 30.98 | 25159151 | |
| 396 | Phosphorylation | ALLESPLSATVEDAL HHHHCCCCCCHHHHH | 25.85 | 28348404 | |
| 398 | Phosphorylation | LESPLSATVEDALQS HHCCCCCCHHHHHHH | 22.50 | 28348404 | |
| 405 | Phosphorylation | TVEDALQSFLKAEEL CHHHHHHHHHHHHHH | 33.14 | 24719451 | |
| 418 | Ubiquitination | ELQPGFSKAGRVYIS HHCCCCCCCCCCHHH | 53.23 | - |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RMD3_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RMD3_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| VATH_HUMAN | ATP6V1H | physical | 22939629 | |
| VATA_HUMAN | ATP6V1A | physical | 22939629 | |
| TOM40_HUMAN | TOMM40 | physical | 22939629 | |
| TI17B_HUMAN | TIMM17B | physical | 22939629 | |
| 1433B_HUMAN | YWHAB | physical | 25862004 | |
| RAF1_HUMAN | RAF1 | physical | 25862004 | |
| MK01_HUMAN | MAPK1 | physical | 25862004 | |
| PTN1_HUMAN | PTPN1 | physical | 25862004 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-46, AND MASSSPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-46, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-44 AND SER-212, AND MASSSPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-46, AND MASSSPECTROMETRY. | |
| "Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-46, AND MASSSPECTROMETRY. | |
| "Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-44, AND MASSSPECTROMETRY. | |